- Home
- BOLT vs ZBAI Comparison
BOLT vs ZBAI Comparison
Compare BOLT & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- ZBAI
- Stock Information
- Founded
- BOLT 2015
- ZBAI 2015
- Country
- BOLT United States
- ZBAI United States
- Employees
- BOLT N/A
- ZBAI N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- ZBAI Professional Services
- Sector
- BOLT Health Care
- ZBAI Consumer Discretionary
- Exchange
- BOLT Nasdaq
- ZBAI Nasdaq
- Market Cap
- BOLT 10.4M
- ZBAI 10.8M
- IPO Year
- BOLT 2021
- ZBAI N/A
- Fundamental
- Price
- BOLT $5.75
- ZBAI $8.38
- Analyst Decision
- BOLT Buy
- ZBAI
- Analyst Count
- BOLT 3
- ZBAI 0
- Target Price
- BOLT $47.50
- ZBAI N/A
- AVG Volume (30 Days)
- BOLT 39.8K
- ZBAI 92.5K
- Earning Date
- BOLT 11-11-2025
- ZBAI 11-12-2025
- Dividend Yield
- BOLT N/A
- ZBAI N/A
- EPS Growth
- BOLT N/A
- ZBAI N/A
- EPS
- BOLT N/A
- ZBAI N/A
- Revenue
- BOLT $4,167,000.00
- ZBAI $720,000.00
- Revenue This Year
- BOLT N/A
- ZBAI N/A
- Revenue Next Year
- BOLT N/A
- ZBAI N/A
- P/E Ratio
- BOLT N/A
- ZBAI N/A
- Revenue Growth
- BOLT N/A
- ZBAI 44.00
- 52 Week Low
- BOLT $4.59
- ZBAI $4.83
- 52 Week High
- BOLT $14.36
- ZBAI $45.00
- Technical
- Relative Strength Index (RSI)
- BOLT 52.63
- ZBAI 49.26
- Support Level
- BOLT $5.62
- ZBAI $7.54
- Resistance Level
- BOLT $6.38
- ZBAI $10.88
- Average True Range (ATR)
- BOLT 0.43
- ZBAI 0.66
- MACD
- BOLT 0.01
- ZBAI -0.23
- Stochastic Oscillator
- BOLT 41.53
- ZBAI 24.25
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.